Market Landscape: Growing Demand for Clinical Trial Software
Innovation and technology are transforming the clinical trial landscape in many ways, including by improving patient recruitment through predictive modeling and optimizing data analysis during trials.
Cutting-edge software can now predict patient eligibility, shortening recruitment times by as much as 30%, while machine learning algorithms help identify potential safety concerns earlier. Wearable devices and remote monitoring tools allow real-time data collection without the need for in-person visits, reducing trial durations by up to 20% and decreasing costs by as much as 15%. These improvements offer a clear financial incentive for pharmaceutical companies and contract research organizations to adopt these innovations. Moreover, as decentralized trials grow, clinical trial software will be crucial in expanding access to more diverse patient populations.
Recent trends demonstrate that the global clinical trial management system market is projected to reach $3.5 billion USD by 2030, growing at a compound annual growth rate (CAGR) of 13.6%. This growth is fueled by the rising need for efficient data management and compliance with stringent regulatory standards (most notably in the EU and U.S.), making clinical trial software an attractive area for investment.
Strategies to Maximize Return on Investment in Clinical Trial Software
Companies with strong differentiation, such as specialized software for rare disease trials, regulatory compliance, or partnerships with major pharmaceutical firms, have established a competitive edge. Investors should prioritize firms with unique capabilities that align with market needs. For example, Greenphire, recognized for its industry-leading clinical trial payment solutions, was acquired by private equity firm Thoma Bravo, underscoring its critical role in streamlining financial processes in clinical trials. Similarly, YPrime secured a strategic partnership with Flexpoint Ford, driven by its innovative e-clinical data management solutions, reinforcing its position as a valuable player in the clinical trial software market.
While the clinical trial software market offers several key investment opportunities, private equity investors should focus on four strategic considerations:
| Market Size and Growth Potential: The sector’s significant projected growth offers fertile ground for private equity investment. Recent estimates are that the global clinical trial software market will reach $5.1 billion USD by 2027, emphasizing the growing demand for scalable digital solutions. |
| Scalability of Solutions: As trials grow more complex, software platforms that can scale to manage large volumes of data and adapt to evolving regulatory frameworks are in demand. This scalability ensures long-term viability and attractiveness to pharmaceutical companies. |
| Intellectual Property and Competitive Moats: Companies with strong intellectual property protections and innovative solutions are better positioned for sustainable growth. Investors should seek firms that stand out through technological innovation and a robust intellectual property portfolio. |
| Recurring Revenue Models: Companies that utilize subscription-based models offer more predictable returns than those reliant on project-based revenues. Recurring revenue models provide financial stability and long-term profitability, making these companies more attractive for investments. |
Recent Significant Deals in the Pharma and Healthcare Technology Market
| Target | Cluepoints | Qualifyze | Sensio | Compile | Endpoint Clinical + Fortrea Patient Access |
| Acquirer | EQT | Insight | Nordic Capital | McKesson | Arsenal Capital Partners |
| Date | Jun-24 | Sep-24 | Jul-24 | Jan-24 | Apr-23 |
| Description | CluePoints provides AI-powered software for Risk-Based Quality Management (RBQM) in clinical trials. | Qualifyze specializes in supply chain compliance software for the life sciences industry. | Sensio is a provider of smart monitoring technology for elderly and social care settings. | Compile is a healthcare data platform that aggregates and integrates data from healthcare providers and patients. | Endpoint is a provider of RTSM solutions into pharma, and Fortrea Patient Access is a specialist in HUB services and patient access. |
| Deal size | Undisclosed | $54 million (Series B funding) | Undisclosed | Undisclosed | Undisclosed |
| Geography | Belgium (Target), Sweden (Acquirer) | Germany (Target), U.S. (Acquirer) | Norway (Target), Sweden (Acquirer) | U.S. (Target), U.S. (Acquirer) | U.S. (Target), U.S. (Acquirer) |
Contributors
Meet Professionals with Complementary Expertise in Healthcare
It’s extremely rewarding to work in one of the largest and most diverse global business sectors helping support clients to realize their goals.
Matthew Lee
Managing Director, Head of UK & Co-head of Healthcare, Europe
London
I enjoy working closely with clients to overcome challenging situations and to develop strategies to meet their business goals.
Dirk-Oliver Löffler
Managing Director & Co-head of Healthcare, Europe
Frankfurt
My goal is to bring the best of Lincoln to each and every transaction, ensuring the topmost outcomes for our clients.
Roderick O’Neill
Managing Director & Co-head of Healthcare
New York
Related Perspectives
Recent Transactions in Healthcare
Strategic Investment Opportunities in the Booming Clinical Trial Software Market
Published in Investors in Healthcare on October 30, 2024. The clinical trial software market is expanding rapidly, driven by the growing complexity of trials and increasing regulatory demands. Pharmaceutical companies,… Read More
Six Key Themes from WEFTEC 2024
Lincoln International recently attended the WEFTEC conference which unites industry professionals and investors in the water and wastewater industry. With 21,000+ participants, 1,000+ exhibitors and a wide range of presentations, workshops… Read More
LA Times | Insights on the Private Equity and M&A Landscape
Originally posted by the LA Times on October 28, 2024. Michael Piric, Managing Director in Lincoln’s Financial Sponsors Group, noted that deal flow didn’t reach anticipated levels by the end of Q3,… Read More
Cybersecurity Report: Q3 2024
Q3 2024 continued to see the strengthening of the cybersecurity M&A market observed in the first half of the year, led by the highest quarterly number of M&A transactions in… Read More
Packaging Quarterly Review Q3 2024
Foodservice packaging has evolved in recent years to align with consumer preferences while maintaining sustainability throughout the manufacturing process. Consumer preferences have gravitated toward food packaging that reduces the risk… Read More
Bloomberg | Lincoln International CEO on Private vs. Public Markets
Originally aired on Bloomberg TV on October 22, 2024. Rob Brown, CEO of Lincoln International, discusses improving mergers and acquisitions activity and compares public and private markets.
M&A Activity in Fire and Life Safety Services Continues to Heat Up
Long-Term Trends Underpinning the Fire and Life Safety Services Industry Amid mounting regulatory oversight and compliance expectations in the fire and life safety services sector, investors are pursuing roll-up strategies.… Read More
Lincoln International and The Chertoff Group Announce Relationship Focused on Government Advisory Services
Creates full complement of risk management & security services for clients Lincoln International, a global investment banking advisory firm and The Chertoff Group, a leader in security risk consulting, federal… Read More
Ryan Hoffman
A career investment banker in the government contracting industry, Ryan provides mergers and acquisitions advisory services to private equity and corporate clients, with a focus on AI/ML, cybersecurity, software and systems engineering, space and geospatial technology… Read More
Jason Kaufman
Jason provides mergers and acquisitions advisory services to corporations and private equity firms, with a focus on AI/ML, cybersecurity, software and systems engineering, space and geospatial technology services, intelligence analysis and… Read More
A “Pan-Premium” Ignites Consolidation in European Fire Safety
Featured in International Fire & Safety Journal on 7 October 2024. Europe’s lukewarm fire safety sector is set to see a wave of mergers and acquisitions (M&A) as players that… Read More
Juan Carlos Montoya
Juan Carlos provides mergers and acquisitions advisory services to corporate and private equity clients across Europe, North America and Asia, with a focus on energy transition. Backed by 15+ years… Read More
Lincoln International adds Juan Carlos Montoya as Managing Director
Lincoln International, a global investment banking advisory firm, is pleased to announce that Juan Carlos Montoya has joined as a Managing Director in the firm’s Industrials Group in Frankfurt. Juan Carlos will… Read More
LA Times | Insights on the Business of Beauty, Fashion and Consumer Goods
Originally posted by the LA Times on September 23, 2024. Ashleigh Barker, Director in Lincoln’s Consumer Group, is optimistic about the outlook for the beauty industry. “While broader consumer discretionary… Read More
North American M&A Set to Accelerate
The mergers and acquisitions (M&A) market is primed for an acceleration. Positive macroeconomic trends, including a projected 200 bps cut in the Fed Funds Rate over the next 12 months,… Read More
Real Deals | Roundtable: Green Shoots for the UK Mid-market
Originally posted by Real Deals on September 18, 2024. The UK and wider market are filled with cautious optimism as macroeconomic challenges cool, providing hope that higher levels of transaction… Read More
Lincoln International Leader Recognized as Beauty and Fashion Visionary
Lincoln International is pleased to announce that Ashleigh Barker, Director in the firm’s U.S. Consumer Group, was selected as a Beauty and Fashion Visionary by the LA Times. “At Lincoln… Read More
Financial News | Lincoln International Eyes Acquisitions in “Aggressive” Expansion, Senior Hiring Spree
Originally published by Financial News on September 8, 2024. Lincoln International leaders Rob Brown, Matthew Lee and Eric Wijs recently shared with Financial News how the firm is hiring experienced… Read More
Continuing momentum in the European TMT sector
Lincoln International’s European Technology Group has announced 21 transactions thus far in 2024. We have seen robust deal activity across all our key Technology subsectors – Business-to-Business (B2B) Software, IT… Read More
Lincoln International adds Brian Little as Managing Director
Lincoln International, a global investment banking advisory firm, is pleased to announce that Brian Little has joined as a Managing Director in the firm’s Consumer Group in Los Angeles. Brian will provide… Read More
Middle Market Dealmaker | Moving Through the Market: 2024 M&A Trends
As H2 2024 ended, M&A market dynamics showed increasing deal volumes despite the growing difficulty in finding quality assets. As a result, the higher-quality deals are over-subscribed, in terms of… Read More
Nils Klemke
Nils provides mergers and acquisitions advisory services to national and international corporate and private equity clients in the healthcare industry, with a focus on provider, pharma and lab services as… Read More
Lincoln International Recognized in 15th Annual International M&A Awards
Lincoln International is pleased to announce that it has been recognized in The M&A Advisor’s 15th Annual International M&A Awards. The firm was honored in the Cross-Border Deal of the… Read More
Brian Little
Brian provides mergers and acquisitions (M&A) advisory services to private equity firms, entrepreneurs and public and private companies in the consumer industry, with a focus on apparel, fashion and accessories.… Read More
Beauty Independent | Will Beauty’s Recent String of Strong Sales Doom the Lipstick Index?
Originally posted by Beauty Independent on August 19, 2024. In 2020, Circana (formerly The NPD Group) estimated prestige beauty sales fell by 19%. Since then, sales have risen each year,… Read More